Reactor shut down will cause global medical isotope shortage Shutting down the current Dutch reactor which produces medical isotopes, without replacing it, puts the world’s supply of medical radio-isotopes at risk.
National Heat Plan no longer in effect as of July 29th As of Monday, 29 July, the National Heat Plan is no longer in effect. The Heat Plan had been active from July 23rd until July 28th. Never before has it been as hot as last week in the Netherlands.
Tick found in Drenthe is a Hyalomma tick RIVM has investigated the so-called giant tick that was found in Odoorn in the province of Drenthe on 13 July. It is a Hyalomma marginatum female.
National Heat Plan active throughout the Netherlands It is forecasted to be exceptionally hot over the coming days. Temperatures will rise to tropical levels. This can lead to problems for people with vulnerable health.
WHO Chemical Risk Assessment Workshop on new and emerging risks to human health from chemicals RIVM is hosting an international workshop on new and emerging risks from chemicals on 20 and 21 February 2019.
Possible health risks due to exposure to chromium-6 at tROM project Tilburg Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.
Kick off European Project VITAL: Vaccines and InfecTious diseases in the Ageing popuLation Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched.
Building blocks for a definition of microplastics The Dutch National Institute for Public Health and the Environment, RIVM has described building blocks for a definition of microplastics.
Jacco Wallinga appointed extraordinary Professor at LUMC From 1 September, Jacco Wallinga will hold the chair in Mathematical Modelling of Infectious Diseases at the department of Medical Statistics and Bio-informatics of the Leiden University Medical Ce
Little incentive from pharmaceutical legislation to promote alternatives to animal testing Current pharmaceutical legislation does not impose any legal constraints on the use of alternatives to animal testing, but neither does it actively encourage the use of these alternatives.